Analyst Group: Brain+ Begins Early Activity and Brand Building in The US

On the 19th of October 2022, Brain+ A/S (“Brain+” or the "Company”) announced that the Company has been selected and featured as a 2022 TMC-Denmark Biobridge Partner in the new Texas Medical Center (TMC) new 2022 Biobridge e-book, hence building early traction within the US market.

Read Analyst Groups comment

About Analyst Group: One of Sweden's leading equity analysis houses with a focus on small and medium-sized listed companies.

Read more about Analyst Group

This is a press release from Analyst Group regarding the publication of comments on Brain+. Readers may assume that Analyst Group has received compensation for making the commentary. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.